130 related articles for article (PubMed ID: 38303308)
21. PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms.
Matthews Hew T; Zuberi L
J Investig Med High Impact Case Rep; 2019; 7():2324709619864989. PubMed ID: 31375040
[TBL] [Abstract][Full Text] [Related]
22. [Long-Term Survival of a Patient with Triple-Negative Breast Cancer with Hormone Receptor Status Conversion between Primary and Metastatic Tumors].
Hayashi K; Harao M; Ogihara K; Sasaki Y; Nishida S; Shiba S; Sakuragi M; Kitayama J; Sata N
Gan To Kagaku Ryoho; 2022 Jun; 49(6):697-699. PubMed ID: 35799399
[TBL] [Abstract][Full Text] [Related]
23. [Occult Breast Carcinoma and Recurrent Tumor in the Breast 14 Years after Axillary Dissection-A Case Report].
Fujimori T; Kasagawa T; Ishii N; Kusashio K; Ozaki D
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2249-2251. PubMed ID: 32156894
[TBL] [Abstract][Full Text] [Related]
24. Unusual recurrent metastasizing benign breast papilloma: a case report.
Jain AL; Mullins J; Smith JR; Valasareddy P; Miller E; Chaudhry A; Ryder J; Hare F; Ranganath H; Berry M; Robins D; Schwartzberg L; Vidal GA
J Med Case Rep; 2020 Feb; 14(1):33. PubMed ID: 32070435
[TBL] [Abstract][Full Text] [Related]
25. [Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report].
Sakurai K; Enomoto K; Tani M; Kitajima A; Amano S; Shiono M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2222-4. PubMed ID: 19106577
[TBL] [Abstract][Full Text] [Related]
26. [A Case of Postoperative Pulmonary Metastasis of Breast Cancer with Complete Response by Abemaciclib plus Fulvestrant Therapy].
Higashi T; Ozawa K; Takei S; Takagi S; Yokoyama M; Mase K; Moriya T; Takeshita A; Mizutani M
Gan To Kagaku Ryoho; 2022 May; 49(5):581-583. PubMed ID: 35578939
[TBL] [Abstract][Full Text] [Related]
27. TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: a case report and literature review.
Ben Musa R; Usha L; Hibbeln J; Mutlu EA
World J Gastroenterol; 2014 May; 20(19):5912-7. PubMed ID: 24914353
[TBL] [Abstract][Full Text] [Related]
28. PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside.
Turk AA; Wisinski KB
Cancer; 2018 Jun; 124(12):2498-2506. PubMed ID: 29660759
[TBL] [Abstract][Full Text] [Related]
29. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
30. [Hereditary Breast and Ovarian Cancer(HBOC)in a Young Adult-A Case Report].
Adachi K; Kubota H; Suzuki S; Hirano T; Ishibashi N; Sakurai K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1843-1845. PubMed ID: 35046349
[TBL] [Abstract][Full Text] [Related]
31. [A long-term survival case of local recurrence of breast cancer treated with combined modality therapy].
Katsuta E; Ohkubo T; Someno Y; Saguchi M; Aoyagi H; Takahata T; Hasegawa K; Hamada S; Kaneko J; Maejima S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2760-2. PubMed ID: 21224704
[TBL] [Abstract][Full Text] [Related]
32. Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer.
Garber HR; Litton JK
Curr Opin Oncol; 2019 May; 31(3):247-255. PubMed ID: 30789866
[TBL] [Abstract][Full Text] [Related]
33. Surgical Bedside Electrochemotherapy for Local Control of a Recurrent Phylloid Malignant Breast Tumor: A Case Report.
Corrado G; Bove S; Alberghetti B; Fragomeni SM; Tagliaferri L; Scambia G; Garganese G
Anticancer Res; 2024 Jan; 44(1):435-439. PubMed ID: 38160000
[TBL] [Abstract][Full Text] [Related]
34. Update on PARP Inhibitors in Breast Cancer.
Zimmer AS; Gillard M; Lipkowitz S; Lee JM
Curr Treat Options Oncol; 2018 Apr; 19(5):21. PubMed ID: 29644491
[TBL] [Abstract][Full Text] [Related]
35. [A Case of Metastatic Breast Cancer with BRCA1 Mutation after Breast Reconstruction and Pregnancy].
Suzuki T; Hashimoto N; Yokoyama K; Yoshida T; Yamauchi Y; Sawano T; Ohashi M; Kimura A; Kato M; Umehara Y; Murata A; Takahash K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1840-1842. PubMed ID: 35046348
[TBL] [Abstract][Full Text] [Related]
36. [A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
Mori K; Chiba N; Yamamoto Y; Yonekawa H
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2565-8. PubMed ID: 12506484
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.
Jacot W; Thezenas S; Senal R; Viglianti C; Laberenne AC; Lopez-Crapez E; Bibeau F; Bleuse JP; Romieu G; Lamy PJ
BMC Cancer; 2013 Nov; 13():523. PubMed ID: 24191908
[TBL] [Abstract][Full Text] [Related]
38. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.
Gelmon KA; Tischkowitz M; Mackay H; Swenerton K; Robidoux A; Tonkin K; Hirte H; Huntsman D; Clemons M; Gilks B; Yerushalmi R; Macpherson E; Carmichael J; Oza A
Lancet Oncol; 2011 Sep; 12(9):852-61. PubMed ID: 21862407
[TBL] [Abstract][Full Text] [Related]
39. [Chemo-Resistant Breast Carcinoma with Cartilaginous Differentiation Manifestation after Neoadjuvant Chemotherapy-A Case Report].
Konishi K; Araya J; Nagabuchi M; Sakamoto T; Takakuwa Y; Sasaki M; Watanabe K; Hirano S
Gan To Kagaku Ryoho; 2021 Jul; 48(7):951-953. PubMed ID: 34267034
[TBL] [Abstract][Full Text] [Related]
40. Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer.
Rafii S; Gourley C; Kumar R; Geuna E; Ern Ang J; Rye T; Chen LM; Shapira-Frommer R; Friedlander M; Matulonis U; De Greve J; Oza AM; Banerjee S; Molife LR; Gore ME; Kaye SB; Yap TA
Oncotarget; 2017 Jul; 8(29):47154-47160. PubMed ID: 28454085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
